Follow the 젠큐릭스 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 젠큐릭스 has logged 4 reports. Market capitalisation: €45.8bn. The latest transaction was disclosed on 14 July 2026 (Other). Among the most active insiders: 조상래. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
젠큐릭스 is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for medical diagnostics.